• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Qingqiu,WU Yun.Medication analysis of clinical pharmacists participating in one patient with severe drug-induced thrombocytopenia[J].Journal Of Pharmaceutical Research,2018,37(6):365-367[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3610times   Download 3720次 QR Code for this article
Scan with your phone!
临床药师参与1例药源性重度血小板减少症的病例分析
周庆秋1,吴云2
Font:Larger+|Default|Smaller-
(1.泰安市中心医院药学部,山东 泰安 271000;2.泰安市中心医院心脏中心,山东 泰安 271000)
摘要:
目的 探讨急性心肌梗死患者经皮冠脉介入治疗术(PCI)后发生严重药源性血小板减少症(DITP)的相关药物。方法 临床药师对该例患者的用药情况进行分析,协助制定药源性血小板减少症的对症治疗方案并全程实施药学监护。结果 临床药师判定替罗非班为致血小板减少症的可疑药物。经对症治疗后,患者血小板逐渐恢复正常,病情缓解出院。结论 临床药师参与药源性血小板减少症患者的治疗与监护,可减少不良反应的发生,保障患者的用药安全。
关键词:  药源性血小板减少症  临床药师  肝素  替罗非班  药学监护
DOI:10.13506/j.cnki.jpr.2018.06.015
基金项目:
Medication analysis of clinical pharmacists participating in one patient with severe drug-induced thrombocytopenia
ZHOU Qingqiu1,WU Yun2
(1.Department of Pharmacy, Taian City Central Hospital,Taian 271000,China;2. Heart Center, Taian City Central Hospital,Taian 271000,China)
Abstract:
Objective To investigate the related drugs of severe drug-induced thrombocytopenia in patients with acute myocardial infarction after percutaneous coronary intervention (PCI).Methods The typical cases participated by clinical pharmacist were shared and analyzed from three aspects of analyzation of drugs that may caused drug-induced thrombocytopenia, formulation of therapeutic regimen and implementation of pharmaceutical care.Results Tirofiban as a suspect drug for thrombocytopenia was identified. Platelets of the patient gradually returned to normal level with symptomatic treatment.The patient discharged after symptomatic remission.Conclusion Clinical pharmacists participated in the treatment and monitoring of patients with drug-induced thrombocytopenia,can reduce the occurrence of adverse reactions,to ensure the safety of patients.
Key words:  Drug-induced thrombocytopenia  Clinical pharmacists  Tirofiban  Heparin  Pharmaceutical care
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.